Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.

書誌詳細
主要な著者:	Isaacs, J, Hale, G, Waldmann, H, Dick, A, Haynes, R, Forrester, J, Watson, P, Meyer, P
フォーマット:	Journal article
言語:	English
出版事項:	1995

類似資料

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
著者:: Newman, D, 等
出版事項: (1995)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
著者:: Isaacs, J, 等
出版事項: (1996)

Campath-1H therapy in refractory ocular inflammatory disease.
著者:: Dick, A, 等
出版事項: (2000)

Specificity of monoclonal antibody Campath-1.
著者:: Hale, G, 等
出版事項: (1988)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
著者:: Hale, G, 等
出版事項: (1994)

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
著者:: Watts, R, 等
出版事項: (1992)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
著者:: Dyer, M, 等
出版事項: (1988)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
著者:: Waldmann, H, 等
出版事項: (1985)

CAMPATH-1H in inflammatory arthritis.
著者:: Watts, R, 等
出版事項: (1993)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
著者:: Friend, P, 等
出版事項: (1991)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
著者:: Waldmann, H, 等
出版事項: (1985)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
著者:: Lim, S, 等
出版事項: (1993)

Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
著者:: Hale, G, 等
出版事項: (1988)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
著者:: Naparstek, E, 等
出版事項: (1999)

REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES
著者:: Dyer, M, 等
出版事項: (1990)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
著者:: Rebello, P, 等
出版事項: (1999)

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
著者:: Williams, R, 等
出版事項: (2000)

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
著者:: Hale, G, 等
出版事項: (1986)

Availability of Campath-1 antibodies for bone marrow transplantation.
著者:: Hale, G, 等
出版事項: (1995)

A personal history of the CAMPATH-1H antibody.
著者:: Waldmann, H
出版事項: (2002)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
著者:: Hale, G, 等
出版事項: (1985)

CAMPATH: from concept to clinic.
著者:: Waldmann, H, 等
出版事項: (2005)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
著者:: Hale, G, 等
出版事項: (1996)

ISOTYPE VARIANTS OF CAMPATH-1 ANTIBODY - REQUIREMENTS FOR EFFECTIVE ANTIBODY ACTION INVIVO
著者:: Dyer, M, 等
出版事項: (1989)

CAMPATH-1 antibodies in stem-cell transplantation.
著者:: Hale, G, 等
出版事項: (2001)

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype.
著者:: Dyer, M, 等
出版事項: (1989)

Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody Campath-6.
著者:: Tighe, H, 等
出版事項: (1988)

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).
著者:: Lundin, J, 等
出版事項: (2002)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
著者:: Naparstek, E, 等
出版事項: (1993)

Sustained remission of severe resistant autoimmune neutropenia with Campath-1H.
著者:: Killick, S, 等
出版事項: (1997)

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
著者:: Hale, G, 等
出版事項: (2002)

Campath 1H (alemtuzumab) in renal transplantation: 5-year comparative follow up.
著者:: Watson, C, 等
出版事項: (2004)

Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-I monoclonal antibody and E-rosetting.
著者:: Morgan, G, 等
出版事項: (1986)

In vivo 'purging' of residual disease in CLL with Campath-1H.
著者:: Dyer, M, 等
出版事項: (1997)

Direct antibody rosette-forming reactions using monoclonal markers of lymphocyte subpopulations. Methodology and applications illustrated by investigations with rat pan-T antibodies of the CAMPATH series.
著者:: Wilson, AB, 等
出版事項: (1986)

1.9 A structure of the therapeutic antibody CAMPATH-1H fab in complex with a synthetic peptide antigen.
著者:: James, L, 等
出版事項: (1999)

Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
著者:: Coles, A, 等
出版事項: (2003)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
著者:: Isaacs, J, 等
出版事項: (1992)

Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up.
著者:: Clatworthy, MR, 等
出版事項: (2009)

Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysis.
著者:: Greenwood, J, 等
出版事項: (1994)